New Fractional Cancer Mathematical Model via IL-10 Cytokine and Anti-PD-L1 Inhibitor
نویسندگان
چکیده
In this study, we explore a recent biological model created to analyze the behavior of cancer cells by administering dose drug containing anti-PD-L1 and IL-10 with Caputo Atangana–Baleanu derivative in sense (ABC). Using order examine stability non-linear system, are able demonstrate that it is existent unique, introduce several numeric data obtained for fractional values MATLAB using Adams–Bashforth–Moulton (ABM) method. Additionally, predictor–corrector approach, numerical results from system ABC will be produced. As result, has been observed immune exposed single-dose effectively combat cells. The tumor decrease 70.44% 80.16% generalized derivative, respectively, α=0.42.
منابع مشابه
The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
The programmed death-1 (PD-1), a coinhibitory receptor expressed on activated T cells and B cells, is demonstrated to induce an immune-mediated response and play a critical role in tumor initiation and development. The cancer patients harboring PD-1 or PD ligand 1 (PD-L1) protein expression have often a poor prognosis and clinical outcome. Currently, targeting PD-1 pathway as a potential new an...
متن کاملImproved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models Jessica Spahn, Jing Peng, Edward Lorenzana, David Kan, Thomas Hunsaker, Ehud Segal, Mario Mautino, Erik Brincks, Andrea Pirzkall, Sean Kelley, Sami Mahrus, Liling Liu, Stephanie Dale, Cristine Quiason, Elizabeth Jones, Yichin Liu,...
متن کاملAnti-PD-1/PD-L1 therapy of human cancer: past, present, and future.
Major progress has been made toward our understanding of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway (referred to as the PD pathway). mAbs are already being used to block the PD pathway to treat human cancers (anti-PD therapy), especially advanced solid tumors. This therapy is based on principles that were discovered through basic research more than a decade ago, but t...
متن کاملControl of Adaptive Immune Responses by Staphylococcus aureus through IL-10, PD-L1, and TLR2
Microbes induce innate immune responses in hosts. It is critical to know how different microbes control adaptive responses through innate pathways. The impact of gram-positive bacteria on the innate and adaptive responses is unclear. Herein we report that Staphylococcus aureus induces IL-10, Th17-inducing cytokines IL-6 and IL-23, chemokines, and regulates dendritic cell markers. S. aureus inhi...
متن کاملCombining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
The interaction of programmed cell death-1 and its ligand is widely studied in cancer. Monoclonal antibodies blocking these molecules have had great success but little is known about them in thyroid cancer. We investigated the role of PD-L1 in thyroid cancer with respect to BRAF mutation and MAP kinase pathway activity and the effect of anti PD-L1 antibody therapy on tumor regression and intra-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Fractal and fractional
سال: 2023
ISSN: ['2504-3110']
DOI: https://doi.org/10.3390/fractalfract7020151